Akuamma (Picralima nitida): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Akuamma work for pain relief?

Akuamma seeds contain indole alkaloids, primarily akuammine and akuammidine, which interact with opioid receptors in the body. Research suggests these compounds bind to mu-opioid receptors, producing analgesic effects similar to conventional opioids but with potentially different receptor profiles. The seeds also contain pericine and alstonine, which may contribute additional anti-inflammatory and antimalarial properties. Evidence level C indicates most mechanistic data comes from laboratory studies rather than controlled human trials.

Can I take Akuamma with prescription medications?

Akuamma should not be combined with sedative medications, including benzodiazepines, barbiturates, or sleep aids, as it may enhance drowsiness and central nervous system depression. The herb's opioid receptor activity could potentially interact with opioid pain medications, though specific clinical interaction data remains limited. Those taking antimalarial drugs should consult a healthcare provider before use. Always disclose all supplements to your prescribing physician to avoid potential interactions.

What is the recommended dosage for Akuamma seeds?

The traditional adult dosage for Akuamma is 2-4 grams of powdered seeds taken daily, typically divided into smaller doses throughout the day. Seeds are most commonly prepared as a powder or decoction. Evidence level C indicates this dosage is based primarily on traditional use and limited pharmacological studies rather than standardized clinical trials. Users should start with the lower end of the dosage range to assess individual tolerance and response.

Is Akuamma safe during pregnancy and breastfeeding?

Akuamma is contraindicated during pregnancy and breastfeeding. Traditional use suggests the herb may stimulate uterine contractions, posing potential risks of miscarriage or premature labor. The alkaloids present, including akuammine, can cross biological barriers and may affect fetal development. Nursing mothers should avoid Akuamma as active compounds may pass into breast milk. Women of childbearing age should use reliable contraception while taking this herb and consult a healthcare provider.

What are the side effects of taking Akuamma?

Common side effects of Akuamma include drowsiness, nausea, and constipation, which are consistent with its opioid receptor activity. These effects are generally dose-dependent and may subside with continued use in some individuals. The sedating properties can impair driving ability and cognitive function. Evidence level C means comprehensive safety profiling is limited, and users should monitor for unexpected reactions. Discontinue use if severe gastrointestinal symptoms or excessive sedation occur.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Akuamma (Picralima nitida) is a West African plant used in traditional medicine for pain, fever, and various other ailments [PMID:24418074, PMID:33326237]. It contains several indole alkaloids that exhibit opioidergic and anti-inflammatory activities [PMID:33326237, PMID:40582228].

Background

Picralima nitida (Apocynaceae) is a plant indigenous to West Africa [PMID:24418074, PMID:41563345].

Traditional uses

In African folk medicine, various parts of the plant are used to treat fever, hypertension, jaundice, dysmenorrhea, gastrointestinal disorders, malaria [PMID:24418074], and cough [PMID:27168749]. The seeds are specifically used for rheumatic fever and as an antipyretic [PMID:24491645].

Active compounds

The plant contains alkaloids (including akuammine, akuammicine, akuammiline, picraline, pseudo-akuammigine, akuammidine, and alstonine), tannins, polyphenols, and steroids [PMID:24418074, PMID:33326237, PMID:40582228].

Mechanism of action

Akuamma alkaloids primarily target opioid receptors; specifically, akuammicine is a potent kappa opioid receptor agonist, while akuammine, pseudo-akuammigine, and akuammicine show micromolar activity at the mu opioid receptor [PMID:33326237]. Seed extracts also suppress PGE2 production by inhibiting COX-2 and mPGES-1 protein expressions and interfering with NF-κB transactivation and MAPK pathways (p38, ERK1/2, and JNK) [PMID:24491645]. Alstonine exhibits antipsychotic action without binding to D2 dopamine receptors [PMID:25636871].

Clinical evidence

Evidence DPain and Inflammation

Seed extracts and isolated alkaloids (e.g., pseudo-akuammigine) demonstrated antinociceptive and anti-inflammatory effects in animal models, including reduction of carrageenan-induced paw edema [PMID:12020930, PMID:32598312].

Evidence DColitis

Total crude alkaloidal extract of seeds protected against acetic acid-induced colonic injury in rats by decreasing mucosal ulceration and inflammatory cell infiltration [PMID:37249276].

Evidence DGastrointestinal Parasites

P. nitida extracts (500 mg/kg) showed significant anthelmintic potential against Heligmosomoides bakeri in rodents [PMID:38222486].

Evidence DDiabetes/Hyperglycemia

Aqueous seed extract improved dyslipidemia and hyperglycemia in high-fat high-fructose-fed rats [PMID:33163962], though another study found seed extract did not show hypoglycemic effects in alloxan-induced diabetic rats [PMID:19069874].

Evidence DAnaemia

Leaf extract produced a significant increase in hemoglobin, haematocrit, and red blood cells in phenyl hydrazine-induced anaemic rats [PMID:37599487].

Safety & adverse effects

A 90-day subchronic toxicity study in albino rodents was conducted to evaluate genotoxicity and safety, though specific results for these endpoints were not detailed in the provided abstract [PMID:30853649]. An aqueous extract of seed and leaf powder (WDP) showed no toxic effect in mice at 2,000 mg/kg [PMID:32598312].

Pregnancy & lactation

The herb is used traditionally in diabetic pregnancy [PMID:23565805], and its safety profile during pregnancy has been noted as a major concern for investigation [PMID:30853649].

Evidence summary

The current evidence is primarily based on in vitro studies and animal models (Level D), demonstrating significant pharmacological potential for analgesia, anti-inflammation, and antimicrobial activity, but lacks human clinical trials.

PubMed sources

1.PMID: 36517579 (2022) — Purification of aquaculture effluent using Picralima nitida seeds. · Scientific reports
2.PMID: 30853649 (2019) — Toxicological evaluation of Picralima nitida in rodents. · Journal of ethnopharmacology
3.PMID: 24418074 (2014) — Medicinal uses, phytochemistry and pharmacology of Picralima nitida (Apocynaceae) in tropical diseases: a review. · Asian Pacific journal of tropical medicine
4.PMID: 24491645 (2014) — Picralima nitida seeds suppress PGE2 production by interfering with multiple signalling pathways in IL-1β-stimulated SK-N-SH neuronal cells. · Journal of ethnopharmacology
5.PMID: 37599487 (2023) — Analysis of haematological effects of Picralima nitida. · Pakistan journal of pharmaceutical sciences

Akuamma

Sources & Citations

Calculate a safe dose of Akuamma